BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8501773)

  • 1. Absent ras gene mutations in human adrenal cortical neoplasms and pheochromocytomas.
    Moul JW; Bishoff JT; Theune SM; Chang EH
    J Urol; 1993 Jun; 149(6):1389-94. PubMed ID: 8501773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point mutations of ras genes in human adrenal cortical tumors: absence in adrenocortical hyperplasia.
    Yashiro T; Hara H; Fulton NC; Obara T; Kaplan EL
    World J Surg; 1994; 18(4):455-60; discussion 460-1. PubMed ID: 7725728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low frequency of ras gene mutations in neuroblastomas, pheochromocytomas, and medullary thyroid cancers.
    Moley JF; Brother MB; Wells SA; Spengler BA; Biedler JL; Brodeur GM
    Cancer Res; 1991 Mar; 51(6):1596-9. PubMed ID: 1998949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infrequent RAS oncogene mutations in human prostate cancer.
    Moul JW; Friedrichs PA; Lance RS; Theune SM; Chang EH
    Prostate; 1992; 20(4):327-38. PubMed ID: 1608859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of the p53 gene in human functional adrenal neoplasms.
    Lin SR; Lee YJ; Tsai JH
    J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
    Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
    Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of RAS mutations in archival testicular germ cell tumors by polymerase chain reaction and oligonucleotide hybridization.
    Moul JW; Theune SM; Chang EH
    Genes Chromosomes Cancer; 1992 Sep; 5(2):109-18. PubMed ID: 1381946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
    Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
    Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 "hot spot" found in Taiwan.
    Reincke M; Wachenfeld C; Mora P; Thumser A; Jaursch-Hancke C; Abdelhamid S; Chrousos GP; Allolio B
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3636-8. PubMed ID: 8855814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 mutations in sporadic adrenocortical tumors.
    Ohgaki H; Kleihues P; Heitz PU
    Int J Cancer; 1993 May; 54(3):408-10. PubMed ID: 8509216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of the c-myc gene in adrenocortical tumors and pheochromocytomas.
    Liu J; Voutilainen R; Kahri AI; Heikkilä P
    J Endocrinol; 1997 Feb; 152(2):175-81. PubMed ID: 9071974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis.
    Namba H; Rubin SA; Fagin JA
    Mol Endocrinol; 1990 Oct; 4(10):1474-9. PubMed ID: 2283998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism.
    Yoshimoto K; Iwahana H; Fukuda A; Sano T; Katsuragi K; Kinoshita M; Saito S; Itakura M
    Jpn J Cancer Res; 1992 Oct; 83(10):1057-62. PubMed ID: 1452458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCR-SSCP analysis of human adrenocortical adenomas: absence of K-ras gene mutations.
    Ocker M; Sachse R; Rico A; Hensen J
    Exp Clin Endocrinol Diabetes; 2000; 108(8):513-4. PubMed ID: 11149627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational status of codons 12 and 13 of the N- and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas.
    Pergolizzi RG; Kreis W; Rottach C; Susin M; Broome JD
    Cancer Invest; 1993; 11(1):25-32. PubMed ID: 7678540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of K-ras oncogene in human adrenal tumours in Taiwan.
    Lin SR; Tsai JH; Yang YC; Lee SC
    Br J Cancer; 1998 Apr; 77(7):1060-5. PubMed ID: 9569040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P
    Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ras mutations in United Kingdom examples of oral malignancies are infrequent.
    Chang SE; Bhatia P; Johnson NW; Morgan PR; McCormick F; Young B; Hiorns L
    Int J Cancer; 1991 May; 48(3):409-12. PubMed ID: 2040536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
    Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
    Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.